NYSE$HCA

HCA Holdings Inc · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Briefing

HCA Healthcare reported Q2 2025 revenues of $18.6B with net income attributable to HCA of $1.65B and diluted EPS of $6.83.

Revenues reached $18.6 billion as same-facility admissions and acuity trends supported volume growth. Net income attributable to HCA Healthcare was $1.65 billion; diluted EPS was $6.83. Labor, supply costs, and payer mix remain key variables for hospital operators.

  • Q2 revenues $18.6B.
  • Net income attributable to HCA $1.65B; diluted EPS $6.83.
  • Volume and acuity trends support revenue.
  • Labor and supply inflation monitored.
  • Capital allocation and share repurchases continue.

Headline financials

Total Revenue

$18.6B

Previous: $17.5B+6.4%
EPS (adj)

$6.83

Previous: $5.53+23.5%
Capital Expenditures

-$2.17B

Previous: -$2.4B+9.7%
Free Cash Flow

-$514M

Previous: -$938M+45.2%
Net Income

$1.65B

Previous: $1.46B+13.1%
Operating Income

$14.7B

Previous: $13.8B+6.6%
Gross Profit

$18.6B

Previous: $17.5B+6.4%
Cash & Equivalents

$939M

Previous: $831M+13.0%
Total Assets

$59.5B

Previous: $57.4B+3.8%

Revenue & EPS history

HCA · Revenue · Quarterly

$18.6B

Q2 2025+6.4%vs Q2 2024
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Forward guidance

Healthcare providers emphasize volume, acuity, labor costs, and payer mix.

Tailwinds

  • Patient volume and service line growth.
  • Cost management and productivity.
  • Capital projects and returns.

Headwinds

  • Nurse and clinician labor inflation.
  • Payer reimbursement pressure.
  • Regulatory and malpractice risk.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2025

Historical avgQ2 2025

-0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+2.9%

Avg return

30 days after

47%

31 / 66 earnings

Positive

+16.1%

Q2 2020

Best reaction

-21.9%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.2%-8.3%-16.8%
Q4 2025+6.2%+3.4%+11.3%
Q3 2025+1.5%+6.4%+11.6%
Q2 2025+0.8%+3.1%+3.8%
Q1 2025-4.0%+1.1%+10.3%
Q4 2024-3.8%+0.7%-2.7%
Q3 2024-10.6%-9.5%-18.5%
Q2 2024+5.7%+9.0%+17.7%
Q1 2024-0.9%-1.5%+1.5%
Q4 2023+6.3%+7.9%+8.7%
Q3 2023-6.5%-6.5%+5.0%
Q2 2023-3.2%-2.9%-3.2%
Q1 2023+5.7%+2.7%+4.3%
Q4 2022-0.6%+2.6%-2.2%
Q3 2022+0.8%+4.3%+10.3%
Q2 2022+9.6%+12.9%+18.6%
Q1 2022-21.9%-21.2%-24.0%
Q4 2021-1.4%-1.1%+5.5%
Q3 2021-7.0%-5.6%-8.1%
Q2 2021+14.5%+14.2%+13.3%
Q1 2021+2.5%+0.7%+4.5%
Q4 2020+3.7%+5.9%+5.6%
Q3 2020-4.4%-9.3%+12.5%
Q2 2020+16.1%+14.6%+21.2%
Q1 2020-5.4%-2.4%-2.2%
Q4 2019+2.6%-2.0%-10.1%
Q3 2019+6.2%+5.3%+10.3%
Q2 2019-8.7%-13.0%-17.4%
Q1 2019-1.1%+0.2%-2.3%
Q4 2018+5.6%+6.1%+5.5%
Q3 2018+3.5%+4.2%+12.0%
Q2 2018+14.9%+14.7%+21.4%
Q1 2018+2.1%+1.9%+7.7%
Q4 2017+3.6%+2.1%+1.9%
Q3 2017+0.9%+0.3%+11.6%
Q2 2017-5.2%-6.6%-7.9%
Q1 2017-1.2%-0.4%-0.1%
Q4 2016+3.4%+5.7%+10.2%
Q3 2016-2.1%-4.5%-9.6%
Q2 2016-1.1%-3.8%-4.8%
Q1 2016-1.7%
Q4 2015+3.1%
Q3 2015-0.1%
Q2 2015-2.8%
Q1 2015-1.2%
Q4 2014-1.7%
Q3 2014-2.1%
Q2 2014+4.1%
Q1 2014-1.2%
Q4 2013-1.0%
Q3 2013-5.1%
Q2 2013+0.1%
Q1 2013+3.8%
Q4 2012-1.1%
Q3 2012+8.0%
Q2 2012+1.1%
Q1 2012-1.1%
Q4 2009+3.5%
Q4 2011+3.5%
Q3 2011+2.6%
Q3 2010+2.6%
Q2 2011-20.6%
Q2 2010-20.6%
Q1 2011-0.2%
Q1 2010-0.2%
Q4 2010-0.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro